- Home
- PHUN vs IXHL Comparison
PHUN vs IXHL Comparison
Compare PHUN & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHUN
- IXHL
- Stock Information
- Founded
- PHUN 2009
- IXHL 2001
- Country
- PHUN United States
- IXHL Australia
- Employees
- PHUN N/A
- IXHL N/A
- Industry
- PHUN EDP Services
- IXHL
- Sector
- PHUN Technology
- IXHL
- Exchange
- PHUN Nasdaq
- IXHL Nasdaq
- Market Cap
- PHUN 55.9M
- IXHL 49.1M
- IPO Year
- PHUN N/A
- IXHL N/A
- Fundamental
- Price
- PHUN $2.92
- IXHL $0.44
- Analyst Decision
- PHUN Buy
- IXHL
- Analyst Count
- PHUN 2
- IXHL 0
- Target Price
- PHUN $7.75
- IXHL N/A
- AVG Volume (30 Days)
- PHUN 250.9K
- IXHL 36.4M
- Earning Date
- PHUN 11-06-2025
- IXHL 11-13-2025
- Dividend Yield
- PHUN N/A
- IXHL N/A
- EPS Growth
- PHUN N/A
- IXHL N/A
- EPS
- PHUN N/A
- IXHL N/A
- Revenue
- PHUN $2,400,000.00
- IXHL $86,000.00
- Revenue This Year
- PHUN N/A
- IXHL $1,188.37
- Revenue Next Year
- PHUN $72.40
- IXHL N/A
- P/E Ratio
- PHUN N/A
- IXHL N/A
- Revenue Growth
- PHUN N/A
- IXHL 616.67
- 52 Week Low
- PHUN $2.22
- IXHL $0.08
- 52 Week High
- PHUN $14.60
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- PHUN 55.90
- IXHL 41.95
- Support Level
- PHUN $2.70
- IXHL $0.43
- Resistance Level
- PHUN $3.13
- IXHL $0.50
- Average True Range (ATR)
- PHUN 0.15
- IXHL 0.07
- MACD
- PHUN 0.02
- IXHL -0.01
- Stochastic Oscillator
- PHUN 55.32
- IXHL 14.47
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.